Forest Products Industry
PPL forges energy partnership with Turkish Petroleum Overseas Company
Thinking of Buying Joby Aviation? Here Are 3 Red Flags to Consider First.
Warren Buffett Just Bought $1.33 Billion Worth of These 3 Stocks
Configure EXO Canter to meet your mill’s needs
EXO Canter is the culmination of decades of experience building complete primary lines. It reflects everything we’ve learned, what works, what doesn’t, and what’s next. Every inch is shaped by the five core values of the Paragon Design Standard, including total configurability.
EXO Canter is not a fixed system, it’s a platform. During the sales phase, mills can select from a wide range of equipment options to build a line that fits their exact needs. Each component is designed to integrate seamlessly, ensuring a cohesive system that performs as one. This modularity supports both greenfield installations and phased upgrades, giving mills the flexibility to scale and adapt over time.
Read the full article on our website and contact your USNR representative to learn more
To read previous USNR related posts click here
Follow IFI on Facebook | LinkedIn | Instagram
The post Configure EXO Canter to meet your mill’s needs appeared first on International Forest Industries.
Dollar drops versus euro, rises slightly against yen, China's rare earths in focus
Global Markets Mixed as Dollar Drops on Fed Rate-Cut Hopes, Gold Reaches New Record
Analyst: Oracle (ORCL) ‘Undercutting Prices’ is ‘Dragging Down’ Cloud Sector Prices – ‘The Market is Becoming Commoditized’
Analyst Says Costco (COST) ‘Story Could Work’ Under These Conditions
Josh Brown Says Philip 66 (PSX) Breakout ‘Could Be Coming’ – Here’s Why
Analyst Bullish on Broadcom (AVGO) Amid an ‘Underappreciated Growth’ Catalyst
Is Vertiv Holdings (VRT) Still a Top AI Stock to Buy for Long Term?
insitro and Bristol Myers Squibb (BMY) Advance ALS Research with New AI-Powered Collaboration
Citi Raises Price Target on Merck (MRK), Citing Strong Pipeline and Oncology Strength
Cantor Fitzgerald Reaffirms Overweight Rating on CVS Health (CVS)
Germany’s Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets
Oppenheimer Highlights Amgen’s (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study
Pages
